HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilie Lommers Selected Research

Myelin-Oligodendrocyte Glycoprotein

2/2022Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort.
11/2018NMOSD with anti-MOG antibodies following anti-TNFα therapy: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emilie Lommers Research Topics

Disease

2Neuromyelitis Optica (Devic's Disease)
02/2022 - 11/2018
1Glioma (Gliomas)
12/2020
1Neoplasms (Cancer)
12/2020
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2018
1Immune Reconstitution Inflammatory Syndrome
02/2012
1Headache (Headaches)
02/2012

Drug/Important Bio-Agent (IBA)

2Myelin-Oligodendrocyte GlycoproteinIBA
02/2022 - 11/2018
2AntibodiesIBA
02/2022 - 11/2018
1Biomarkers (Surrogate Marker)IBA
12/2020
1SteroidsIBA
02/2012
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2012
1DNA (Deoxyribonucleic Acid)IBA
02/2012
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2012
1Natalizumab (Tysabri)FDA Link
02/2012

Therapy/Procedure

1Therapeutics
11/2018
1Plasma Exchange
02/2012